Ergoteles LLC Corcept Therapeutics Inc Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$17.33 - $25.3 $101,553 - $148,258	-5,860 Reduced 11.19%	46,489 $1.11 Million
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $437,201 - $666,779	-26,449 Reduced 33.57%	52,349 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $1.17 Million - $1.6 Million	68,660 Added 677.25%	78,798 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $357,605 - $409,392	-18,171 Reduced 64.19%	10,138 $200,000
Q2 2021 Aug 12, 2021	BUY	$19.97 - $24.43 $565,330 - $691,588	28,309 New	28,309 $623,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.